Defence Therapeutics Inc (DTC.CX)
0.51
+0.01
(+2.00%)
CAD |
CNSX |
Aug 25, 16:00
Defence Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Spectral Medical, Inc. | -186.3% |
| Resverlogix Corp. | -- |
| Theratechnologies, Inc. | -- |
| COSCIENS Biopharma, Inc. | 55.27% |
| Restart Life Sciences Corp. | -80.76% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.43K% |
| Return on Assets | -180.3% |
| Return on Invested Capital | -310.2% |
| Return on Net Operating Assets | -3.11K% |